Publications by authors named "Fushen Sha"

Claim this Profile
C
Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma.
Fushen Sha, Michelle Okwali, Anna Alperovich, Philip C Caron, Lorenzo Falchi, Venkatraman E Seshan

Blood Cancer J· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical benefit of neoadjuvant anti-PD-1/PD-L1 utilization among different tumors.
Zhiyang Li, Xin Wu, Yanjie Zhao, Yinan Xiao, Yunuo Zhao, Fushen Sha

MedComm (2020)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines.
Yinan Xiao, Hanyue Xu, Wen Guo, Yunuo Zhao, Yuling Luo, Fushen Sha

Mol Biomed· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups.
Connie L Batlevi, Fushen Sha, Anna Alperovich, Ai Ni, Katy Smith, Venkatraman E Seshan

Blood Cancer J· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positron-emission tomography-based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma.
Connie L Batlevi, Fushen Sha, Anna Alperovich, Ai Ni, Katy Smith, Venkatraman E Seshan

Eur J Cancer· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of survival in patients with recurrent mantle cell lymphoma in the modern era: progressive shortening in response duration and survival after each relapse.
Anita Kumar, Fushen Sha, Ahmed Toure, Ahmet Dogan, Andy Ni

Blood Cancer J· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical presentation determines selection of patients for initial observation in mantle cell lymphoma.
Anita Kumar, Zhitao Ying, Anna Alperovich, Ahmet Dogan, Paul Hamlin, Fushen Sha

Haematologica· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-183 potentially inhibits NF-κB1 expression by directly targeting its 3'-untranslated region.
Fushen Sha, Shuangxing Wu, Hui Zhang, Xuemin Guo

Acta Biochim Biophys Sin (Shanghai)· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis